Covid-19 Impact on Prenatal and New-born Genetic Testing Market, Global Research Reports 2020-2021
This report covers market size and forecasts of Prenatal and New-born Genetic Testing, including the following market information:
Major competitors identified in this market include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Natera, Inc., Illumina, Inc., Ariosa Diagnostics, Perkin Elmer, Verinata Health, Sequenom, Inc., etc.
Based on the Region:
- Global Prenatal and New-born Genetic Testing Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Prenatal and New-born Genetic Testing Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Prenatal and New-born Genetic Testing Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Prenatal and New-born Genetic Testing Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Major competitors identified in this market include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Natera, Inc., Illumina, Inc., Ariosa Diagnostics, Perkin Elmer, Verinata Health, Sequenom, Inc., etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- PCR
- FISH
- aCGH
- NIPT
- MSS
- Hospital
- Clinic
- Others
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Prenatal and New-born Genetic Testing Industry
1.7 COVID-19 Impact: Prenatal and New-born Genetic Testing Market Trends
2 GLOBAL PRENATAL AND NEW-BORN GENETIC TESTING QUARTERLY MARKET SIZE ANALYSIS
2.1 Prenatal and New-born Genetic Testing Business Impact Assessment - COVID-19
2.1.1 Global Prenatal and New-born Genetic Testing Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Prenatal and New-born Genetic Testing Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Prenatal and New-born Genetic Testing Quarterly Market Size, 2019 VS 2020
3.2 By Players, Prenatal and New-born Genetic Testing Headquarters and Area Served
3.3 Date of Key Players Enter into Prenatal and New-born Genetic Testing Market
3.4 Key Players Prenatal and New-born Genetic Testing Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON PRENATAL AND NEW-BORN GENETIC TESTING SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 PCR
1.4.2 FISH
1.4.3 aCGH
1.4.4 NIPT
1.4.5 MSS
4.2 By Type, Global Prenatal and New-born Genetic Testing Market Size, 2019-2021
5 IMPACT OF COVID-19 ON PRENATAL AND NEW-BORN GENETIC TESTING SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Hospital
5.5.2 Clinic
5.5.3 Others
5.2 By Application, Global Prenatal and New-born Genetic Testing Market Size, 2019-2021
5.2.1 By Application, Global Prenatal and New-born Genetic Testing Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Agilent Technologies, Inc.
7.1.1 Agilent Technologies, Inc. Business Overview
7.1.2 Agilent Technologies, Inc. Prenatal and New-born Genetic Testing Quarterly Revenue, 2020
7.1.3 Agilent Technologies, Inc. Prenatal and New-born Genetic Testing Product Introduction
7.1.4 Agilent Technologies, Inc. Response to COVID-19 and Related Developments
7.2 Bio-Rad Laboratories, Inc.
7.2.1 Bio-Rad Laboratories, Inc. Business Overview
7.2.2 Bio-Rad Laboratories, Inc. Prenatal and New-born Genetic Testing Quarterly Revenue, 2020
7.2.3 Bio-Rad Laboratories, Inc. Prenatal and New-born Genetic Testing Product Introduction
7.2.4 Bio-Rad Laboratories, Inc. Response to COVID-19 and Related Developments
7.3 Natera, Inc.
7.3.1 Natera, Inc. Business Overview
7.3.2 Natera, Inc. Prenatal and New-born Genetic Testing Quarterly Revenue, 2020
7.3.3 Natera, Inc. Prenatal and New-born Genetic Testing Product Introduction
7.3.4 Natera, Inc. Response to COVID-19 and Related Developments
7.4 Illumina, Inc.
7.4.1 Illumina, Inc. Business Overview
7.4.2 Illumina, Inc. Prenatal and New-born Genetic Testing Quarterly Revenue, 2020
7.4.3 Illumina, Inc. Prenatal and New-born Genetic Testing Product Introduction
7.4.4 Illumina, Inc. Response to COVID-19 and Related Developments
7.5 Ariosa Diagnostics
7.5.1 Ariosa Diagnostics Business Overview
7.5.2 Ariosa Diagnostics Prenatal and New-born Genetic Testing Quarterly Revenue, 2020
7.5.3 Ariosa Diagnostics Prenatal and New-born Genetic Testing Product Introduction
7.5.4 Ariosa Diagnostics Response to COVID-19 and Related Developments
7.6 Perkin Elmer
7.6.1 Perkin Elmer Business Overview
7.6.2 Perkin Elmer Prenatal and New-born Genetic Testing Quarterly Revenue, 2020
7.6.3 Perkin Elmer Prenatal and New-born Genetic Testing Product Introduction
7.6.4 Perkin Elmer Response to COVID-19 and Related Developments
7.7 Verinata Health
7.7.1 Verinata Health Business Overview
7.7.2 Verinata Health Prenatal and New-born Genetic Testing Quarterly Revenue, 2020
7.7.3 Verinata Health Prenatal and New-born Genetic Testing Product Introduction
7.7.4 Verinata Health Response to COVID-19 and Related Developments
7.8 Sequenom, Inc.
7.8.1 Sequenom, Inc. Business Overview
7.8.2 Sequenom, Inc. Prenatal and New-born Genetic Testing Quarterly Revenue, 2020
7.8.3 Sequenom, Inc. Prenatal and New-born Genetic Testing Product Introduction
7.8.4 Sequenom, Inc. Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Prenatal and New-born Genetic Testing Industry
1.7 COVID-19 Impact: Prenatal and New-born Genetic Testing Market Trends
2 GLOBAL PRENATAL AND NEW-BORN GENETIC TESTING QUARTERLY MARKET SIZE ANALYSIS
2.1 Prenatal and New-born Genetic Testing Business Impact Assessment - COVID-19
2.1.1 Global Prenatal and New-born Genetic Testing Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Prenatal and New-born Genetic Testing Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Prenatal and New-born Genetic Testing Quarterly Market Size, 2019 VS 2020
3.2 By Players, Prenatal and New-born Genetic Testing Headquarters and Area Served
3.3 Date of Key Players Enter into Prenatal and New-born Genetic Testing Market
3.4 Key Players Prenatal and New-born Genetic Testing Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON PRENATAL AND NEW-BORN GENETIC TESTING SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 PCR
1.4.2 FISH
1.4.3 aCGH
1.4.4 NIPT
1.4.5 MSS
4.2 By Type, Global Prenatal and New-born Genetic Testing Market Size, 2019-2021
5 IMPACT OF COVID-19 ON PRENATAL AND NEW-BORN GENETIC TESTING SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Hospital
5.5.2 Clinic
5.5.3 Others
5.2 By Application, Global Prenatal and New-born Genetic Testing Market Size, 2019-2021
5.2.1 By Application, Global Prenatal and New-born Genetic Testing Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Agilent Technologies, Inc.
7.1.1 Agilent Technologies, Inc. Business Overview
7.1.2 Agilent Technologies, Inc. Prenatal and New-born Genetic Testing Quarterly Revenue, 2020
7.1.3 Agilent Technologies, Inc. Prenatal and New-born Genetic Testing Product Introduction
7.1.4 Agilent Technologies, Inc. Response to COVID-19 and Related Developments
7.2 Bio-Rad Laboratories, Inc.
7.2.1 Bio-Rad Laboratories, Inc. Business Overview
7.2.2 Bio-Rad Laboratories, Inc. Prenatal and New-born Genetic Testing Quarterly Revenue, 2020
7.2.3 Bio-Rad Laboratories, Inc. Prenatal and New-born Genetic Testing Product Introduction
7.2.4 Bio-Rad Laboratories, Inc. Response to COVID-19 and Related Developments
7.3 Natera, Inc.
7.3.1 Natera, Inc. Business Overview
7.3.2 Natera, Inc. Prenatal and New-born Genetic Testing Quarterly Revenue, 2020
7.3.3 Natera, Inc. Prenatal and New-born Genetic Testing Product Introduction
7.3.4 Natera, Inc. Response to COVID-19 and Related Developments
7.4 Illumina, Inc.
7.4.1 Illumina, Inc. Business Overview
7.4.2 Illumina, Inc. Prenatal and New-born Genetic Testing Quarterly Revenue, 2020
7.4.3 Illumina, Inc. Prenatal and New-born Genetic Testing Product Introduction
7.4.4 Illumina, Inc. Response to COVID-19 and Related Developments
7.5 Ariosa Diagnostics
7.5.1 Ariosa Diagnostics Business Overview
7.5.2 Ariosa Diagnostics Prenatal and New-born Genetic Testing Quarterly Revenue, 2020
7.5.3 Ariosa Diagnostics Prenatal and New-born Genetic Testing Product Introduction
7.5.4 Ariosa Diagnostics Response to COVID-19 and Related Developments
7.6 Perkin Elmer
7.6.1 Perkin Elmer Business Overview
7.6.2 Perkin Elmer Prenatal and New-born Genetic Testing Quarterly Revenue, 2020
7.6.3 Perkin Elmer Prenatal and New-born Genetic Testing Product Introduction
7.6.4 Perkin Elmer Response to COVID-19 and Related Developments
7.7 Verinata Health
7.7.1 Verinata Health Business Overview
7.7.2 Verinata Health Prenatal and New-born Genetic Testing Quarterly Revenue, 2020
7.7.3 Verinata Health Prenatal and New-born Genetic Testing Product Introduction
7.7.4 Verinata Health Response to COVID-19 and Related Developments
7.8 Sequenom, Inc.
7.8.1 Sequenom, Inc. Business Overview
7.8.2 Sequenom, Inc. Prenatal and New-born Genetic Testing Quarterly Revenue, 2020
7.8.3 Sequenom, Inc. Prenatal and New-born Genetic Testing Product Introduction
7.8.4 Sequenom, Inc. Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Prenatal and New-born Genetic Testing Assessment
Table 9. COVID-19 Impact: Prenatal and New-born Genetic Testing Market Trends
Table 10. COVID-19 Impact Global Prenatal and New-born Genetic Testing Market Size
Table 11. Global Prenatal and New-born Genetic Testing Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Prenatal and New-born Genetic Testing Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Prenatal and New-born Genetic Testing Market Growth Drivers
Table 14. Global Prenatal and New-born Genetic Testing Market Restraints
Table 15. Global Prenatal and New-born Genetic Testing Market Opportunities
Table 16. Global Prenatal and New-born Genetic Testing Market Challenges
Table 17. By Players, Prenatal and New-born Genetic Testing Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Prenatal and New-born Genetic Testing Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Prenatal and New-born Genetic Testing Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Prenatal and New-born Genetic Testing Market
Table 21. Key Players Prenatal and New-born Genetic Testing Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Prenatal and New-born Genetic Testing Market Size 2019-2021, (US$ Million)
Table 24. Global Prenatal and New-born Genetic Testing Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Prenatal and New-born Genetic Testing Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 57. Agilent Technologies, Inc. Business Overview
Table 58. Agilent Technologies, Inc. Prenatal and New-born Genetic Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Agilent Technologies, Inc. Prenatal and New-born Genetic Testing Product
Table 60. Agilent Technologies, Inc. Response to COVID-19 and Related Developments
Table 61. Bio-Rad Laboratories, Inc. Business Overview
Table 62. Bio-Rad Laboratories, Inc. Prenatal and New-born Genetic Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Bio-Rad Laboratories, Inc. Prenatal and New-born Genetic Testing Product
Table 64. Bio-Rad Laboratories, Inc. Response to COVID-19 and Related Developments
Table 65. Natera, Inc. Business Overview
Table 66. Natera, Inc. Prenatal and New-born Genetic Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Natera, Inc. Prenatal and New-born Genetic Testing Product
Table 68. Natera, Inc. Response to COVID-19 and Related Developments
Table 69. Illumina, Inc. Business Overview
Table 70. Illumina, Inc. Prenatal and New-born Genetic Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Illumina, Inc. Prenatal and New-born Genetic Testing Product
Table 72. Illumina, Inc. Response to COVID-19 and Related Developments
Table 73. Ariosa Diagnostics Business Overview
Table 74. Ariosa Diagnostics Prenatal and New-born Genetic Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Ariosa Diagnostics Prenatal and New-born Genetic Testing Product
Table 76. Ariosa Diagnostics Response to COVID-19 and Related Developments
Table 77. Perkin Elmer Business Overview
Table 78. Perkin Elmer Prenatal and New-born Genetic Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Perkin Elmer Prenatal and New-born Genetic Testing Product
Table 80. Perkin Elmer Response to COVID-19 and Related Developments
Table 81. Verinata Health Business Overview
Table 82. Verinata Health Prenatal and New-born Genetic Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Verinata Health Prenatal and New-born Genetic Testing Product
Table 84. Verinata Health Response to COVID-19 and Related Developments
Table 85. Sequenom, Inc. Business Overview
Table 86. Sequenom, Inc. Prenatal and New-born Genetic Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Sequenom, Inc. Prenatal and New-born Genetic Testing Product
Table 88. Sequenom, Inc. Response to COVID-19 and Related Developments
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Prenatal and New-born Genetic Testing Assessment
Table 9. COVID-19 Impact: Prenatal and New-born Genetic Testing Market Trends
Table 10. COVID-19 Impact Global Prenatal and New-born Genetic Testing Market Size
Table 11. Global Prenatal and New-born Genetic Testing Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Prenatal and New-born Genetic Testing Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Prenatal and New-born Genetic Testing Market Growth Drivers
Table 14. Global Prenatal and New-born Genetic Testing Market Restraints
Table 15. Global Prenatal and New-born Genetic Testing Market Opportunities
Table 16. Global Prenatal and New-born Genetic Testing Market Challenges
Table 17. By Players, Prenatal and New-born Genetic Testing Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Prenatal and New-born Genetic Testing Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Prenatal and New-born Genetic Testing Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Prenatal and New-born Genetic Testing Market
Table 21. Key Players Prenatal and New-born Genetic Testing Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Prenatal and New-born Genetic Testing Market Size 2019-2021, (US$ Million)
Table 24. Global Prenatal and New-born Genetic Testing Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Prenatal and New-born Genetic Testing Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Prenatal and New-born Genetic Testing Market Size, 2019-2021 (US$ Million)
Table 57. Agilent Technologies, Inc. Business Overview
Table 58. Agilent Technologies, Inc. Prenatal and New-born Genetic Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Agilent Technologies, Inc. Prenatal and New-born Genetic Testing Product
Table 60. Agilent Technologies, Inc. Response to COVID-19 and Related Developments
Table 61. Bio-Rad Laboratories, Inc. Business Overview
Table 62. Bio-Rad Laboratories, Inc. Prenatal and New-born Genetic Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Bio-Rad Laboratories, Inc. Prenatal and New-born Genetic Testing Product
Table 64. Bio-Rad Laboratories, Inc. Response to COVID-19 and Related Developments
Table 65. Natera, Inc. Business Overview
Table 66. Natera, Inc. Prenatal and New-born Genetic Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Natera, Inc. Prenatal and New-born Genetic Testing Product
Table 68. Natera, Inc. Response to COVID-19 and Related Developments
Table 69. Illumina, Inc. Business Overview
Table 70. Illumina, Inc. Prenatal and New-born Genetic Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Illumina, Inc. Prenatal and New-born Genetic Testing Product
Table 72. Illumina, Inc. Response to COVID-19 and Related Developments
Table 73. Ariosa Diagnostics Business Overview
Table 74. Ariosa Diagnostics Prenatal and New-born Genetic Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Ariosa Diagnostics Prenatal and New-born Genetic Testing Product
Table 76. Ariosa Diagnostics Response to COVID-19 and Related Developments
Table 77. Perkin Elmer Business Overview
Table 78. Perkin Elmer Prenatal and New-born Genetic Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Perkin Elmer Prenatal and New-born Genetic Testing Product
Table 80. Perkin Elmer Response to COVID-19 and Related Developments
Table 81. Verinata Health Business Overview
Table 82. Verinata Health Prenatal and New-born Genetic Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Verinata Health Prenatal and New-born Genetic Testing Product
Table 84. Verinata Health Response to COVID-19 and Related Developments
Table 85. Sequenom, Inc. Business Overview
Table 86. Sequenom, Inc. Prenatal and New-born Genetic Testing Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Sequenom, Inc. Prenatal and New-born Genetic Testing Product
Table 88. Sequenom, Inc. Response to COVID-19 and Related Developments
LIST OF FIGURES
Figure 1. Prenatal and New-born Genetic Testing Product Picture
Figure 2. Prenatal and New-born Genetic Testing Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Prenatal and New-born Genetic Testing Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Prenatal and New-born Genetic Testing Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Prenatal and New-born Genetic Testing Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Prenatal and New-born Genetic Testing Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Prenatal and New-born Genetic Testing Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Prenatal and New-born Genetic Testing Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Prenatal and New-born Genetic Testing Market Size Market Share, 2019-2021
Figure 1. Prenatal and New-born Genetic Testing Product Picture
Figure 2. Prenatal and New-born Genetic Testing Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Prenatal and New-born Genetic Testing Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Prenatal and New-born Genetic Testing Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Prenatal and New-born Genetic Testing Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Prenatal and New-born Genetic Testing Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Prenatal and New-born Genetic Testing Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Prenatal and New-born Genetic Testing Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Prenatal and New-born Genetic Testing Market Size Market Share, 2019-2021
